Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.45M Buy
18,207
+39
+0.2% +$19.8K 0.18% 104
2026
Q1
$9.01M Sell
18,168
-278
-2% -$131K 0.2% 93
2025
Q4
$7.87M Buy
18,446
+8,983
+95% +$3.85M 0.17% 113
2025
Q3
$4.5M Sell
9,463
-580
-6% -$275K 0.14% 155
2025
Q2
$4.71M Buy
10,043
+7,266
+262% +$3.32M 0.15% 160
2025
Q1
$1.29M Sell
2,777
-665
-19% -$299K 0.1% 179
2024
Q4
$1.44M Buy
+3,442
New +$1.57M 0.09% 187

Other funds holding LIN

Callan Family Office's LIN Position: Q2 2026 in Review

Callan Family Office increased its Linde (LIN) stake by 0.21% in Q2 2026, buying an estimated $19.8K and bringing the position to 18,207 shares worth $9.45M. The position accounts for 0.18% of the portfolio, ranked #104.

Callan Family Office first reported a position in LIN in Q4 2024 and has held it in 7 quarters since. 2,350 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Callan Family Office held 18,207 shares of Linde worth $9.45M as of Q2 2026.
  • Callan Family Office bought 39 Linde shares in Q2 2026, an estimated $19.8K.
  • Linde made up 0.18% of Callan Family Office's portfolio in Q2 2026, its #104 holding.
  • Callan Family Office first reported a position in Linde in Q4 2024 and has held it in 7 quarters since.
  • 2,350 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.